ENO2 and lung carcinoma: Several protein biomarkers for lung cancer are being developed, including cytokeratin-19 fragments (CYFRA 21-1) [5,6], carcinoembryonic antigen (CEA) [7], neuron-specific enolase (NSE) [8], and cancer antigen-125 (CA-125) [9].